With the discovery of PSA (Prostatic Specific Antigen) tumor marker, prostate cancer is now diagnosed early in many asymptomatic patients on routine medical examination or screening in the developed world [2,3]. This evidence concerns the gene KLK3 and prostate carcinoma.